Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 116 clinical trials
featured
  • 0 views
  • 24 Jun, 2021
  • 1 location
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

To evaluate the safety and efficacy of LKA651 in patients with macular edema from diabetic macular edema (DME),

lucentis
type 2 diabetes mellitus
spectral domain optical coherence tomography
diabetes
  • 130 views
  • 01 Aug, 2021
  • 24 locations
Safety Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (DME)

This study is intended to assess the safety, tolerability and evidence of pharmacodynamic activity of a single intravitreal (IVT) injection of UBX1325 in patients with diabetic macular edema

  • 0 views
  • 16 Aug, 2021
  • 33 locations
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema

Efficacy duration of triamcinolone acetonide (steroid) for treatment of diabetic macular edema. Furthermore, dosage dependency of triamcinolone acetonide comparing a high dosage versus a

triamcinolone
edema
diabetic macular edema
macular edema
  • 33 views
  • 07 Nov, 2020
  • 1 location
iOCT for Patients With Diabetic Macular Edema

Patients will be examined before and after surgery with a stand-alone OCT and intraoperative microscope integrated OCT

cataract
  • 12 views
  • 30 Jan, 2021
  • 1 location
Micropulse for Suppression of Diabetic Macular Edema

Diabetic retinopathy is one of the most common complications of diabetes and diabetic macular edema (DME) is one of the most common causes of vision loss in diabetes. The purpose of this

corrected visual acuity
diabetes
blindness
type 2 diabetes mellitus
retinopathy
  • 30 views
  • 01 May, 2021
  • 1 location
Evaluation of RC28-E Injection in Diabetic Macular Edema

This is a non-randomized, open-label, multicenter, 48-week study to investigate the efficacy, safety and pharmacokinetics of RC28-E injection in the treatment of patients with diabetic macular

  • 0 views
  • 02 May, 2021
  • 1 location
Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

will be randomized if diabetic macular edema persists. Each subject will be evaluated for 6 months following randomization. Thus, the study duration will be 12 months plus the recruitment period.

retinal edema
dexamethasone
aflibercept
diabetic retinopathy
corrected visual acuity
  • 0 views
  • 31 Jul, 2021
  • 1 location
To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema

The purpose of this study is to evaluate the efficacy and safety of brolucizumab in treatment of Chinese patients with visual impairment due to Diabetic Macular Edema.

visual impairment
diabetes
aflibercept
brolucizumab
type 2 diabetes mellitus
  • 0 views
  • 14 Apr, 2021
  • 15 locations
Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema

mg AXT107 in approximately 18 subjects (up to 6 subjects per dose) with Diabetic Macular Edema (DME).

  • 0 views
  • 03 Mar, 2021
  • 10 locations